NCT05230355Completed
Comparison Between Two Techniques of Subthreshold Diode Laser Cyclophotocoagulation in Refractory Glaucoma
Source: ClinicalTrials.gov · Last updated 10 Jul 2025
Brief summary (registry, in English)
The aim of this study is to assess the results of subliminal subthreshold transscleral diode cyclophotocoagulation in refractory glaucoma using the standard technique of 360 degree application and to compare the outcome with a modified technique both in terms of efficacy and safety.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 32 (actual)
- First submitted
- 20 Jan 2022
- Start date
- 1 Feb 2022
- Primary completion date
- 1 Aug 2024
- Lead sponsor
- Assiut University
- Diseases
- Glaucoma
- NCT number
- NCT05230355
What you commit to
- Study type: Interventional
- Participants enrolled: 32
- From 1 Feb 2022 to the primary completion date, 1 Aug 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Recent ocular surgery in the study eye in the 2 months prior to enrolment.
Other illness
- Ocular infection.
Other
- Ocular inflammation.
Who the study is looking for
- patients with refractory glaucoma (IOP \> 21 mmHg unresponsive to maximally tolerated antiglaucoma medications, previously failed surgical treatment, or both)
Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Assiut University Coordinator of this site? Confirm its status | Asyut | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.